Corcept Therapeutics Incorporated (CORT) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -16.77M | 38.45M | 54.48M | 43.94M | 5.13M | 59.3M | 73.83M | 41.18M | 23.76M | 5.89M | 52.91M | 42.29M | 25.96M | 33.39M | 33.65M | 18.04M | 35.25M | 49.43M | 48.7M | 44.34M |
| Operating CF Margin % | -10.17% | 19.02% | 26.24% | 22.6% | 3.26% | 32.6% | 40.44% | 25.14% | 16.18% | 4.35% | 42.81% | 35.92% | 24.57% | 32.4% | 33.08% | 17.45% | 37.62% | 50.02% | 50.66% | 48.41% |
| Operating CF Growth % | -427.07% | -35.16% | -26.21% | 6.69% | -78.41% | 907.3% | 39.54% | -2.61% | -8.48% | -82.37% | 57.24% | 134.4% | -26.36% | -32.45% | -30.91% | -59.31% | 38.65% | 40.93% | 59.98% | -16.63% |
| Net Income | -31.76M | 98.17M | 19.36M | 35.15M | 20.55M | 30.39M | 46.69M | 35.12M | 27.76M | 31.36M | 31.38M | 27.53M | 15.88M | 16.6M | 34.61M | 27.41M | 22.8M | 32.05M | 30.47M | 26.52M |
| Depreciation & Amortization | 598K | 482K | 477K | 469K | 462K | 460K | 499K | 257K | 179K | 630K | 289K | 823K | 859K | 747K | 752K | 668K | 802K | 797K | 771K | 756K |
| Stock-Based Compensation | 23.04M | -63.73M | 0 | 19.02M | 21.83M | 16.8M | 0 | 0 | 13.25M | 13.06M | 12.88M | 11.86M | 11.14M | 10.52M | 10.55M | 10.61M | 10.76M | 10.81M | 10.95M | 11.07M |
| Deferred Taxes | -13.11M | 0 | 9.11M | -17.76M | -13.71M | -3.86M | -15.21M | -13.96M | -7.16M | -3.67M | -8.86M | -10.24M | -6.73M | -4.47M | -8.87M | -10.63M | -9.94M | 2.3M | 4.11M | 3.3M |
| Other Non-Cash Items | -3.95M | 1.38M | 22.18M | -1.31M | -1.69M | -1.83M | 13.76M | 12.49M | -2.86M | -3.19M | -2.75M | -1.68M | -1.5M | -738K | 251K | 764K | 1.11M | 1.29M | 1.33M | 1.28M |
| Working Capital Changes | 8.41M | 2.14M | 3.35M | 8.37M | -22.31M | 17.35M | 28.09M | 7.28M | -7.41M | -32.3M | 19.98M | 13.99M | 6.31M | 10.72M | -3.64M | -10.78M | 9.72M | 2.18M | 1.07M | 1.42M |
| Change in Receivables | 20.71M | 9.84M | -5.06M | -2.75M | -7.84M | 5.74M | -5.88M | 7.68M | -6.39M | -6.5M | -2.07M | 4K | -1.5M | -15.64M | -1.25M | -986K | 447K | -1.12M | 1.11M | -5.42M |
| Change in Inventory | -3.27M | 483K | -3.94M | -4.63M | 605K | -78K | 1.08M | -1.68M | 983K | 329K | -544K | 922K | 558K | 125K | 419K | 818K | -163K | 789K | 797K | 992K |
| Change in Payables | -7.64M | 6M | 10.92M | -4.78M | 12.93M | -3.86M | -113K | 6.59M | -4.86M | 995K | 8.59M | -3.15M | -649K | 4.24M | -165K | -1.58M | 2.26M | 364K | -2.66M | 2.19M |
| Cash from Investing | 4.54M | -11.84M | 14.64M | 70.13M | -3.17M | -64.36M | -44.04M | -60.19M | -9.01M | 17.1M | -109.57M | -24.1M | 207.47M | -17.24M | -4.79M | -41.8M | -50.5M | 140.47M | -25.8M | 24.74M |
| Capital Expenditures | -201K | -50K | 0 | -57K | -104K | -121K | -1.64M | -416K | 0 | 0 | -37K | -102K | 0 | -31K | -351K | -19K | -12K | -65K | -159K | -119K |
| CapEx % of Revenue | 0.12% | 0.02% | - | 0.03% | 0.07% | 0.07% | 0.9% | 0.25% | - | - | 0.03% | 0.09% | - | 0.03% | 0.34% | 0.02% | 0.01% | 0.07% | 0.17% | 0.13% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 760K | -31.22M | -46.41M | -102.93M | -39.8M | -4.56M | -21.09M | -2.15M | -543K | 766K | -3.92M | -145.75M | 181K | -61K | -13.96M | -2.76M | -506K | -206.97M | -23.64M | -26.03M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 750K | -36.54M | -38.26M | -90.51M | 0 | 0 | -9.44M | -241K | 0 | 0 | 0 | -143.93M | 0 | 0 | 0 | 0 | 0 | -207.5M | -25.77M | -29.17M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -5.76M | -36.54M | -42.46M | -103.02M | 0 | 0 | -11.71M | -3.48M | 0 | 0 | 0 | -145.43M | 0 | 0 | 0 | 0 | 0 | -207.5M | -25.77M | -29.17M |
| Other Financing | 10K | 5.32M | -8.15M | -12.43M | -39.8M | -4.56M | -11.65M | -1.91M | -543K | 766K | -3.92M | -1.82M | 181K | -61K | -13.96M | -2.76M | -506K | 531K | 2.13M | 3.14M |
| Net Change in Cash | -11.76M | -4.64M | 22.39M | 12.93M | -37.85M | -9.62M | 8.7M | -21.16M | 14.2M | 23.75M | -60.58M | -127.56M | 233.61M | 16.09M | 14.9M | -26.52M | -15.76M | -17.07M | -742K | 43.05M |
| Free Cash Flow | -16.97M | 38.4M | 54.48M | 43.88M | 5.02M | 59.18M | 72.19M | 40.77M | 23.76M | 5.89M | 52.87M | 42.18M | 25.96M | 33.36M | 33.3M | 18.02M | 35.23M | 49.36M | 48.55M | 44.22M |
| FCF Margin % | -10.29% | 19% | 26.24% | 22.57% | 3.2% | 32.54% | 39.55% | 24.89% | 16.18% | 4.35% | 42.78% | 35.84% | 24.57% | 32.37% | 32.73% | 17.43% | 37.61% | 49.95% | 50.5% | 48.28% |
| FCF Growth % | -437.84% | -35.12% | -24.54% | 7.64% | -78.85% | 905.25% | 36.54% | -3.36% | -8.48% | -82.35% | 58.79% | 134.08% | -26.33% | -32.42% | -31.41% | -59.25% | 39.29% | 42.5% | 63.31% | -16.78% |
| FCF per Share | -0.16 | 0.32 | 0.46 | 0.36 | 0.04 | 0.50 | 0.63 | 0.37 | 0.22 | 0.05 | 0.48 | 0.38 | 0.22 | 0.29 | 0.29 | 0.16 | 0.31 | 0.40 | 0.39 | 0.35 |
| FCF Conversion (FCF/Net Income) | 0.54x | 1.58x | 2.77x | 1.25x | 0.25x | 1.95x | 1.58x | 1.16x | 0.86x | 0.19x | 1.69x | 1.54x | 1.63x | 2.01x | 0.97x | 0.66x | 1.55x | 1.54x | 1.60x | 1.67x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |